Literature DB >> 18983838

The stabilisation of purified, reconstituted P-glycoprotein by freeze drying with disaccharides.

Adam Heikal1, Karl Box2, Alice Rothnie3, Janet Storm3, Richard Callaghan3, Marcus Allen4.   

Abstract

The drug efflux pump P-glycoprotein (P-gp) (ABCB1) confers multidrug resistance, a major cause of failure in the chemotherapy of tumours, exacerbated by a shortage of potent and selective inhibitors. A high throughput assay using purified P-gp to screen and characterise potential inhibitors would greatly accelerate their development. However, long-term stability of purified reconstituted ABCB1 can only be reliably achieved with storage at -80 degrees C. For example, at 20 degrees C, the activity of ABCB1 was abrogated with a half-life of <1 day. The aim of this investigation was to stabilise purified, reconstituted ABCB1 to enable storage at higher temperatures and thereby enable design of a high throughput assay system. The ABCB1 purification procedure was optimised to allow successful freeze drying by substitution of glycerol with the disaccharides trehalose or maltose. Addition of disaccharides resulted in ATPase activity being retained immediately following lyophilisation with no significant difference between the two disaccharides. However, during storage trehalose preserved ATPase activity for several months regardless of the temperature (e.g. 60% retention at 150 days), whereas ATPase activity in maltose purified P-gp was affected by both storage time and temperature. The data provide an effective mechanism for the production of resilient purified, reconstituted ABCB1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18983838      PMCID: PMC2791872          DOI: 10.1016/j.cryobiol.2008.10.125

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  47 in total

1.  Short term stability of freeze-dried, lyoprotected liposomes.

Authors:  E C van Winden; D J Crommelin
Journal:  J Control Release       Date:  1999-03-08       Impact factor: 9.776

2.  Effects of trehalose on the phase behavior of DPPC-cholesterol unilamellar vesicles.

Authors:  Satoshi Ohtake; Carolina Schebor; Juan J de Pablo
Journal:  Biochim Biophys Acta       Date:  2006-01-27

3.  Residue G346 in transmembrane segment six is involved in inter-domain communication in P-glycoprotein.

Authors:  Janet Storm; Megan L O'Mara; Emily H Crowley; Jonathan Peall; D Peter Tieleman; Ian D Kerr; Richard Callaghan
Journal:  Biochemistry       Date:  2007-08-14       Impact factor: 3.162

Review 4.  Expression and function of efflux drug transporters in the intestine.

Authors:  Mikihisa Takano; Ryoko Yumoto; Teruo Murakami
Journal:  Pharmacol Ther       Date:  2005-10-04       Impact factor: 12.310

Review 5.  Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.

Authors:  Szabolcs Modok; Howard R Mellor; Richard Callaghan
Journal:  Curr Opin Pharmacol       Date:  2006-05-11       Impact factor: 5.547

6.  Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding.

Authors:  S D Allison; B Chang; T W Randolph; J F Carpenter
Journal:  Arch Biochem Biophys       Date:  1999-05-15       Impact factor: 4.013

7.  Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma.

Authors:  Lajos Pusztai; Peter Wagner; Nuhad Ibrahim; Edgardo Rivera; Richard Theriault; Daniel Booser; Fraser W Symmans; Franklin Wong; George Blumenschein; Donald R Fleming; Roman Rouzier; Graeme Boniface; Gabriel N Hortobagyi
Journal:  Cancer       Date:  2005-08-15       Impact factor: 6.860

8.  Stabilization of phosphofructokinase with sugars during freeze-drying: characterization of enhanced protection in the presence of divalent cations.

Authors:  J F Carpenter; L M Crowe; J H Crowe
Journal:  Biochim Biophys Acta       Date:  1987-01-20

9.  Cryoprotection of phosphofructokinase with organic solutes: characterization of enhanced protection in the presence of divalent cations.

Authors:  J F Carpenter; S C Hand; L M Crowe; J H Crowe
Journal:  Arch Biochem Biophys       Date:  1986-11-01       Impact factor: 4.013

Review 10.  How can we best use structural information on P-glycoprotein to design inhibitors?

Authors:  Christopher A McDevitt; Richard Callaghan
Journal:  Pharmacol Ther       Date:  2006-11-18       Impact factor: 12.310

View more
  3 in total

1.  Chapter 11 - Reconstitution of membrane proteins in phospholipid bilayer nanodiscs.

Authors:  T K Ritchie; Y V Grinkova; T H Bayburt; I G Denisov; J K Zolnerciks; W M Atkins; S G Sligar
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

2.  The cystic fibrosis transmembrane conductance regulator (CFTR): three-dimensional structure and localization of a channel gate.

Authors:  Mark F Rosenberg; Liam P O'Ryan; Guy Hughes; Zhefeng Zhao; Luba A Aleksandrov; John R Riordan; Robert C Ford
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

Review 3.  Reconstitution of membrane proteins into model membranes: seeking better ways to retain protein activities.

Authors:  Hsin-Hui Shen; Trevor Lithgow; Lisa Martin
Journal:  Int J Mol Sci       Date:  2013-01-14       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.